Anavex Life Sciences (AVXL) Short Interest Ratio & Short Volume

Anavex Life Sciences logo
$2.59 +0.05 (+1.97%)
Closing price 06/23/2026 03:58 PM Eastern
Extended Trading
$2.60 +0.01 (+0.31%)
As of 08:00 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Anavex Life Sciences Short Interest Overview

As of May 29, 2026, Anavex Life Sciences (AVXL) had a short interest of 18.83 million shares sold short, representing 22.84% of the public float. This marks a -2.07% decrease in short interest since the prior report. The short interest ratio (days to cover) is 16.6, meaning it would take 16.6 days of the average trading volume of 1.50 million shares to cover all short positions.

Current Short Interest
18,834,525 shares
Previous Short Interest
19,232,245 shares
Change Vs. Previous Month
-2.07%
Dollar Volume Sold Short
$57.07 million
Short Interest Ratio
16.6 Days to Cover
Last Record Date
May 29, 2026
Outstanding Shares
92,670,000 shares
Short Percent of Float
22.84%
Today's Trading Volume
775,950 shares
Average Trading Volume
1,504,166 shares
Today's Volume Vs. Average
52%
Short Selling Anavex Life Sciences?
A Guide To High-Short-Interest Stocks

Sign up to receive the latest short interest report for Anavex Life Sciences and its competitors with MarketBeat's FREE newsletter.

Get Report
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Short Interest History

AVXL Short Interest Over Time

AVXL Days to Cover Over Time

AVXL Percentage of Float Shorted Over Time

Anavex Life Sciences Tesla Short Interest History & Recent Changes

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
5/29/202618,834,525 shares $57.07 million -2.1%22.8%16.63 $3.03
5/15/202619,232,245 shares $55.97 million +1.2%23.4%19.62 $2.91
4/30/202619,011,626 shares $63.50 million +0.3%23.1%22.76 $3.34
4/15/202618,950,432 shares $61.40 million -1.6%23.1%17.17 $3.24
3/31/202619,262,453 shares $59.14 million -9.2%23.5%6.95 $3.07
3/13/202621,206,863 shares $98.61 million +4.1%25.7%21.27 $4.65
2/27/202620,366,318 shares $90.22 million -0.8%24.8%21.58 $4.43
2/13/202620,532,909 shares $80.69 million +2.9%24.9%13.17 $3.93
1/30/202619,953,236 shares $93.78 million +0.8%25.1%16.19 $4.70
1/15/202619,787,447 shares $95.97 million +0.7%24.9%12.28 $4.85
12/31/202519,650,578 shares $69.96 million -14.7%24.7%8.01 $3.56
12/15/202523,042,899 shares $95.40 million -8.3%29.0%9.08 $4.14
11/28/202525,139,901 shares $95.78 million -12.5%31.6%6.75 $3.81
11/14/202528,742,805 shares $104.62 million +7.8%37.6%6.27 $3.64
10/31/202526,664,141 shares $212.51 million +0.2%34.9%26.45 $7.97
10/15/202526,620,000 shares $240.38 million +6.0%34.8%23.8 $9.03
9/30/202525,110,000 shares $223.48 million +1.1%N/A22.6 $8.90
9/15/202524,840,000 shares $225.80 million -2.6%N/A22.8 $9.09
8/31/202525,510,000 shares $245.92 million +0.6%33.5%24.3 $9.64
8/15/202525,370,000 shares $252.18 million +2.3%N/A25.4 $9.94
7/31/202524,810,000 shares $280.35 million -1.4%32.8%24.3 $11.30
7/15/202525,150,000 shares $273.38 million +0.1%N/A26.3 $10.87
6/30/202525,120,000 shares $231.61 million -0.4%33.2%27 $9.22
6/15/202525,210,000 shares $202.44 million +0.7%33.3%26.6 $8.03
5/31/202525,030,000 shares $188.48 million +3.9%33.1%25.4 $7.53
5/15/202524,100,000 shares $201.72 million +2.6%31.8%23.6 $8.37
4/30/202523,490,000 shares $223.16 million -2.2%N/A23.3 $9.50
4/15/202524,010,000 shares $218.97 million -2.4%31.7%22.7 $9.12
3/31/202524,590,000 shares $210.98 million +2.3%32.5%18.8 $8.58
3/15/202524,040,000 shares $226.70 million +2.6%31.8%14.9 $9.43
2/28/202523,440,000 shares $185.41 million -3.1%31.0%14.2 $7.91
2/15/202524,200,000 shares $206.18 million +3.3%32.0%14.2 $8.52
1/31/202523,430,000 shares $217.20 million +0.1%N/A12.9 $9.27
1/15/202523,400,000 shares $265.12 million +7.3%N/A12.3 $11.33
12/31/202421,800,000 shares $234.13 million +4.7%N/A12.7 $10.74
12/15/202420,820,000 shares $176.14 million +5.7%N/A15.8 $8.46
11/30/202419,690,000 shares $186.27 million +4.7%N/A17.3 $9.46
11/15/202418,810,000 shares $140.04 million +2.7%N/A18.1 $7.45
10/31/202418,310,000 shares $121.21 million +2.2%N/A21.1 $6.62
10/15/202417,910,000 shares $96.53 million +1.8%N/A22.7 $5.39
The Treasury just bought its own debt (Ad)

On April 16th, the U.S. Treasury executed a $15 billion buyback of its own debt - the largest in history - while former Treasury Secretary Hank Paulson publicly warned of collapsing demand for U.S. bonds. According to Garrett Goggin, CFA, CMT, with 20 years studying gold and debt cycles, this is the moment miners priced for a world that no longer exists stand to benefit most. As natural bond buyers disappear and the Fed steps in, the move in gold may only be beginning.tc pixel

See the four gold miners positioned to benefit from what comes next
9/30/202417,590,000 shares $99.91 million -10.3%N/A19.5 $5.68
9/15/202419,610,000 shares $104.13 million +1.1%N/A20.1 $5.31
8/31/202419,390,000 shares $116.73 million -1.8%N/A17.8 $6.02
8/15/202419,750,000 shares $124.62 million -0.7%N/A17.2 $6.31
7/31/202419,880,000 shares $135.08 million +7.8%N/A16.3 $6.80
7/15/202418,440,000 shares $107.51 million +3.4%N/A15.8 $5.83
6/30/202417,830,000 shares $75.24 million -14.9%N/A15.4 $4.22
6/15/202420,940,000 shares $78.94 million -4.0%N/A17.6 $3.77
5/31/202421,820,000 shares $88.59 million -0.2%N/A17.6 $4.06
5/15/202421,860,000 shares $98.15 million +2.7%N/A17.5 $4.49
4/30/202421,290,000 shares $77.71 million -3.3%N/A16.6 $3.65
4/15/202422,010,000 shares $93.10 million -0.5%N/A17.1 $4.23
3/31/202422,120,000 shares $112.59 million +10.6%N/A17.3 $5.09
3/15/202420,000,000 shares $102.20 million -0.1%N/A13.4 $5.11
2/29/202420,020,000 shares $102.90 million +0.7%N/A13.9 $5.14
2/15/202419,890,000 shares $115.96 million -1.2%N/A13.7 $5.83
1/31/202420,130,000 shares $120.18 million -2.6%N/A13.9 $5.97
1/15/202420,660,000 shares $123.75 million +2.9%N/A14.4 $5.99
12/31/202320,070,000 shares $186.85 million +10.8%N/A14.8 $9.31
12/15/202318,120,000 shares $160.18 million +0.8%N/A16.6 $8.84
11/30/202317,970,000 shares $129.56 million -0.8%N/A17.6 $7.21
11/15/202318,120,000 shares $111.98 million -2.6%N/A18.8 $6.18
10/31/202318,610,000 shares $103.84 million +4.5%N/A20.3 $5.58
10/15/202317,810,000 shares $107.75 million -0.9%N/A20.5 $6.05
9/30/202317,970,000 shares $117.70 million +5.2%N/A21.8 $6.55
9/15/202317,090,000 shares $129.37 million +1.2%N/A20.4 $7.57
8/31/202316,880,000 shares $133.35 million +1.0%N/A19.3 $7.90
8/15/202316,720,000 shares $149.48 million +1.1%N/A18.5 $8.94
7/31/202316,540,000 shares $136.46 million -1.1%N/A18.1 $8.25
7/15/202316,730,000 shares $140.87 million -0.1%N/A18.8 $8.42
6/30/202316,740,000 shares $136.10 million -5.6%N/A17.8 $8.13
6/15/202317,740,000 shares $156.64 million +7.5%N/A17.9 $8.83
5/31/202316,510,000 shares $152.55 million +3.8%N/A15.9 $9.24
5/15/202315,900,000 shares $150.89 million +10.6%N/A15.9 $9.49
4/30/202314,380,000 shares $117.05 million -7.8%N/A13.7 $8.14
4/15/202315,590,000 shares $122.85 million -1.9%N/A14.4 $7.88
3/31/202315,890,000 shares $136.18 million +1.3%N/A13.8 $8.57
3/15/202315,680,000 shares $146.76 million -3.9%N/A13.2 $9.36
2/28/202316,320,000 shares $155.37 million -4.7%N/A7.5 $9.52
2/15/202317,130,000 shares $179.35 million +2.5%N/A7.4 $10.47
1/31/202316,720,000 shares $181.75 million -9.0%N/A7.1 $10.87
1/15/202318,370,000 shares $194.35 million +0.7%N/A8.1 $10.58
12/30/202218,250,000 shares $169.00 million +15.7%N/A8.2 $9.26
12/15/202215,780,000 shares $131.76 million +32.5%N/A7.3 $8.35
11/30/202211,910,000 shares $105.05 million +17.1%N/A6 $8.82
11/15/202210,170,000 shares $142.89 million +0.6%N/A11.6 $14.05
10/31/202210,110,000 shares $123.04 million +0.7%N/A12.7 $12.17
10/15/202210,040,000 shares $106.42 million -2.1%N/A12.5 $10.60
9/30/202210,260,000 shares $105.88 million +5.3%N/A13 $10.32
9/15/20229,740,000 shares $92.63 million +7.0%N/A12.1 $9.51
A drilling crew just broke a record nobody expected (Ad)

A drilling crew in Beaver County, Utah hit 15,765 feet of solid granite in 16 days - a job the Department of Energy projected would take 64. They reached DOE's 2035 performance targets twelve years early, cutting costs in half within 18 months. When Congress moved to cut solar and wind tax credits, this energy source kept its full credits through 2033. One company has been building in this space for sixty years, and a July 4th catalyst is now 12 days away.tc pixel

See the company at the center of Project FORGE right now
8/31/20229,100,000 shares $87.27 million +8.0%N/A10.6 $9.59
8/15/20228,430,000 shares $100.06 million -3.4%N/A9.6 $11.87
7/31/20228,730,000 shares $89.57 million +5.7%N/A9.3 $10.26
7/15/20228,260,000 shares $104.90 million -5.2%N/A8.8 $12.70
6/30/20228,710,000 shares $87.19 million -8.3%N/A9.7 $10.01
6/15/20229,500,000 shares $76.95 million +6.6%N/A10.6 $8.10
5/31/20228,910,000 shares $81.17 million +1.5%N/A10.1 $9.11
5/15/20228,780,000 shares $75.42 million +8.0%N/A9.4 $8.59
4/30/20228,130,000 shares $69.84 million +3.2%N/A8.5 $8.59
4/15/20227,880,000 shares $87.47 million +3.6%N/A6.9 $11.10
3/31/20227,610,000 shares $93.68 million -5.4%N/A6.3 $12.31
3/15/20228,040,000 shares $85.63 million +2.4%N/A6.6 $10.65
2/28/20227,850,000 shares $86.04 million No ChangeN/A6.6 $10.96
2/15/20227,850,000 shares $99.85 million +34.0%N/A6.4 $12.72
1/31/20225,860,000 shares $76.65 million +21.1%N/A5.1 $13.08
1/15/20224,840,000 shares $69.65 million +7.6%N/A5.2 $14.39
12/31/20214,500,000 shares $78.03 million -6.8%N/A5.3 $17.34
12/15/20214,830,000 shares $92.45 million +0.4%N/A5.8 $19.14
11/30/20214,810,000 shares $93.31 million +9.1%N/A5.9 $19.40
11/15/20214,410,000 shares $94.82 million -14.0%9.9%5.5 $21.50
10/29/20215,130,000 shares $96.14 million +0.4%11.5%6.1 $18.74
10/15/20215,110,000 shares $89.53 million -12.2%11.5%5.3 $17.52
9/30/20215,820,000 shares $104.47 million +3.4%13.1%4.8 $17.95
9/15/20215,630,000 shares $96.10 million -5.5%N/A3.2 $17.07
8/31/20215,960,000 shares $116.16 million -14.1%N/A2.3 $19.49
8/13/20216,940,000 shares $135.68 million +3.7%N/A2.6 $19.55
7/30/20216,690,000 shares $120.09 million -12.0%N/A2.5 $17.95
7/15/20217,600,000 shares $168.42 million -13.3%N/A3.1 $22.16
6/30/20218,770,000 shares $200.48 million +24.9%12.5%3.7 $22.86

AVXL Short Interest - Frequently Asked Questions

Short interest is the volume of Anavex Life Sciences shares that have been sold short but have not yet been covered or closed out. As of May 29th, traders have sold 18,834,525 shares of AVXL short. 22.84% of Anavex Life Sciences' shares are currently sold short. Learn More on Anavex Life Sciences' current short interest.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. AVXL shares currently have a short interest ratio of 16.6. Learn More on Anavex Life Sciences's short interest ratio.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 22.84% of Anavex Life Sciences' floating shares are currently sold short.

Anavex Life Sciences saw a decrease in short interest in May. As of May 29th, there was short interest totaling 18,834,525 shares, a decrease of 2.1% from the previous total of 19,232,245 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

22.84% of Anavex Life Sciences' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Anavex Life Sciences: Cronos Group Inc. (1.03%), Corvus Pharmaceuticals, Inc. (25.66%), ARS Pharmaceuticals, Inc. (38.78%), Xencor, Inc. (15.49%), Cullinan Therapeutics, Inc. (14.19%), BioAge Labs, Inc. (5.08%), DBV Technologies S.A. (2.85%), Evotec AG (0.02%), Pharming Group N.V. Sponsored ADR (0.01%), Arbutus Biopharma Corporation (10.73%),

As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($81.27 billion), Invesco QQQ ($49.06 billion), iShares Russell 2000 ETF ($23.61 billion), Western Digital Corporation ($16.93 billion), Sandisk Corporation ($15.61 billion), Salesforce Inc. ($11.65 billion), SPDR S&P Biotech ETF ($10.52 billion), Nebius Group N.V. ($10.24 billion), Lumentum Holdings Inc. ($8.74 billion), and iShares iBoxx $ High Yield Corporate Bond ETF ($8.21 billion). View all of the most shorted stocks.

Short selling AVXL is an investing strategy that aims to generate trading profit from Anavex Life Sciences as its price is falling. AVXL shares are trading up $0.05 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Anavex Life Sciences occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of AVXL, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including AVXL, twice per month. The most recent reporting period available is May, 29 2026.

Understanding short interest metrics can help you assess how traders are positioning around a stock like AVXL:

  • Shares Sold Short: The total number of shares that have been sold by short sellers but have not yet been covered or closed out. A high number may indicate bearish sentiment.
  • Short Float: The percentage of a company’s publicly available shares (or "float") that are sold short. A higher short float suggests a greater portion of the stock is being bet against.
  • Days to Cover (Short Interest Ratio): This estimates how many days it would take short sellers to cover their positions, based on average daily trading volume. Higher values can signal potential for a short squeeze if buying pressure increases.

These metrics are often used by traders to gauge sentiment, volatility risk, and the potential for price movements based on short covering activity.



This page (NASDAQ:AVXL) was last updated on 6/9/2026 by MarketBeat.com Staff.
From Our Partners